Stock UniverseDerived research view · source repositories remain read-only

Enovis Corporation (ENOV)

Life Science Tools / Diagnostics / MedTech · Healthcare / Medical Devices
Score Band
Watch
Selection Score
34.76
Global Rank
1309
Market Cap
1.46B
Latest Close
23.78
RS Composite
-16.58% · G#2472

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-4.31%
3M
-2.98%
6M
-18.78%
1Y
-25.29%
3Y
-54.90%
5Y
-68.74%
10Y
-49.00%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 563.67K · 30-day average: 1.11M · Max drawdown over stored range: -76.46%

Research Snapshot

Relative Strength vs SPX

RS Composite-16.58%
20D RS-13.37%
60D RS-13.24%
120D RS-21.52%
Global RS Rank2472 · 26.32% percentile
Watch+Speculative RS Rank1529 · 27.09% percentile
Group ScopeWatch+Speculative
Primary RS Rank98 · 30.99% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank88 / 246
Primary Percentile64.63
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-04-032026-05-072.28B1.38B-1.07B-1.14B-19.88287.42M337.81M-50.39M57M60.50%-47.00%-49.91%12.62%-2.21%33.13M1.29B

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-04-03$-19.88-1.2x$39.830.6x$-0.88-27.0x$5.024.7x

Shares Diluted: 57M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue1120.71426.1881563.1011707.1972107.6232248.049
Revenue Growth (YoY)-66.32%27.259%9.6%9.219%23.455%6.663%
Gross Profit610.24793.633883.92993.5421250.4131368.725
Operating Income-38.401-14.708-15.097-7.36154.21973.2975
Free Cash Flow187.15251.862-161.31112.765-67.2119.917
Free Cash Flow Per Share4.1054.925-2.9840.234-1.2160.349
EPS (Diluted) GAAP0.9327441.401154-0.249015-0.61266-14.932949-20.754661
EPS Growth10200%50.218%10200%10200%10200%
EPS Non-GAAP
Gross Margin54.452%55.647%56.549%58.197%59.328%60.885%
Operating Margin-3.427%-1.031%-0.966%-0.431%2.573%3.26%
Profit Margin3.803%5.024%-0.85%-1.948%-39.167%-52.687%
Free Cash Flow Margin16.699%17.66%-10.32%0.748%-3.189%0.886%
Shares Outstanding (Diluted)45.588751.141254.065454.494855.280657.0686
Shares Change (YoY)0.073%12.18%5.718%0.794%1.442%3.234%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-07589.15M62.04%6.53M1.11%-8.76M-1.49%-0.1557.31M33.13M1.29Bprocessed
2025 Q42026-02-26575.76M60.69%-502.18M-87.22%-520.59M-90.42%-9.1057.19M36.39M1.26Bprocessed
2025 Q32025-11-06548.91M59.92%-558.49M-1.02%-571.15M-1.04%-9.9957.17M33.62M1.34Bprocessed
2025 Q22025-08-07564.54M59.29%-16.80M-2.98%-36.74M-6.51%-0.6457.13M44.07M1.37Bprocessed
2025 Q12025-05-08558.83M59.45%-46.77M-8.37%-55.97M-10.01%-0.9856.79M38.46M1.37Bprocessed
2024 Q42025-02-26560.98M54.82%-664.75M-1.18%-703.34M-1.25%-12.5855.91M48.17M1.31Bprocessed
2024 Q32024-11-06505.22M56.70%-31.74M-6.28%-31.52M-6.24%-0.5855.67M35.42M1.33Bprocessed
2024 Q22024-08-07525.16M55.01%-44.22M-8.42%-18.64M-3.55%-0.3454.86M35.00M1.33Bprocessed
2024 Q12024-05-02516.27M57.70%-35.01M-6.78%-72.00M-13.95%-1.3254.69M66.27M1.32Bprocessed
2023 Q42024-02-22455.02M58.10%-5.75M-1.26%2.96M0.65%0.0554.59M36.19M466.16Mprocessed
2023 Q32023-11-07417.52M58.19%-20.49M-4.91%-2.88M-0.69%-0.0554.55M32.13M395.00Mprocessed
2023 Q22023-08-03428.50M57.96%-14.49M-3.38%-9.99M-2.33%-0.1854.51M32.49M400.00Mprocessed
2023 Q12023-05-04406.15M57.88%-24.97M-6.15%-23.35M-5.75%-0.4354.33M21.90M285.00Mprocessed
2022 Q42023-03-01408.71M56.70%-28.18M-6.90%-38.60M-9.45%-0.7352.88M24.30M40.00Mprocessed
2022 Q32022-11-02383.81M56.23%-17.92M-4.67%-66.61M-17.36%-1.2354.14M54.96M449.22Mprocessed
2022 Q22022-08-04395.12M54.64%5.55M1.41%76.86M19.45%1.4154.52M95.61M449.46Mprocessed
2022 Q12022-05-101.02B42.04%53.12M5.19%n/an/a0.2854.41M661.50M1.65Bprocessed
2021 FY2021-11-04965.89M41.92%63.99M6.62%n/an/a0.16161.17M177.48M1.61Bprocessed
2021 FY2021-07-28985.93M42.50%75.94M7.70%n/an/a0.18155.86M62.31M1.58Bprocessed
2021 FY2021-04-29879.21M42.21%61.31M6.97%n/an/a0.13141.77M763.65M1.48Bprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.